Long-term efficacy and safety of nilotinib therapy after imatinib failure in eosinophilic myeloproliferative neoplasm and ETV6-ABL rearrangement
暂无分享,去创建一个
R. Fanin | E. Ottaviani | D. Barraco | M. Medeot | M. Tiribelli | D. Damiani | F. De Marchi | L. Marin